Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
Clinical trial NCT01599559 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01599559
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2022-06-17
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.